The basic pharmaceutical products and preparations manufacturing output in Finland experienced fluctuations from 2013 to 2023. From a value of €1.7 billion in 2013, it increased, peaking at €2.55 billion in 2023. The sector observed both growth and contractions, with significant jumps in 2016 (up by 19.35%) and 2022 (up by 17.34%). The recent years saw modest growth, with a 1.43% increase from 2022 to 2023. Over the last five years (2018-2023), the compound annual growth rate (CAGR) settled at 2.89%.
Future trends: Forecasts indicate steady growth, with output expected to reach €2.91 billion by 2028, reflecting a 5-year CAGR of 2.13%. Key trends to monitor include advancements in biotechnology, the impact of healthcare policies, and global market dynamics.
